Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 22, 2007
Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin
A Conen, M Weisser, C Orasch Jörg, et al.
Bone Marrow Transplantation
|
August 11, 2010
High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML
A O'Meara, T Pabst, D Heim, et al.
Bone Marrow Transplantation
|
June 16, 2010
Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT
N Cantoni, S Gerull, D Heim, et al.
Leukemia & Lymphoma
|
August 13, 2009
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)
R Zenhäusern, S-F Hsu Schmitz, M Solenthaler, et al.
International Journal of Laboratory Hematology
|
August 27, 2009
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood
A Rovó, G Stüssi, S Meyer-Monard, et al.
Bone Marrow Transplantation
|
July 25, 2007
The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable
J-M Tiercy, G Nicoloso, J Passweg, et al.
Acta Neuropathologica
|
December 14, 1999
Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE)
O Schaller, R Fatzer, M Stack, et al.
Diabetes, Nutrition & Metabolism
|
April 27, 2000
Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year study
H Hasche, G Mertes, C Bruns, et al.
Bone Marrow Transplantation
|
June 30, 2009
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies
G Stussi, J Halter, A Tichelli, et al.
Swiss Medical Weekly
|
May 12, 2010
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations
C Taverna, M Bargetzi, D Betticher, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 22, 2007
Candida krusei--a serious complication in patients with hematological malignancies: successful treatment with caspofungin
A Conen, M Weisser, C Orasch Jörg, et al.
Bone Marrow Transplantation
|
August 11, 2010
High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML
A O'Meara, T Pabst, D Heim, et al.
Bone Marrow Transplantation
|
June 16, 2010
Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT
N Cantoni, S Gerull, D Heim, et al.
Leukemia & Lymphoma
|
August 13, 2009
Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98)
R Zenhäusern, S-F Hsu Schmitz, M Solenthaler, et al.
International Journal of Laboratory Hematology
|
August 27, 2009
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood
A Rovó, G Stüssi, S Meyer-Monard, et al.
Bone Marrow Transplantation
|
July 25, 2007
The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable
J-M Tiercy, G Nicoloso, J Passweg, et al.
Acta Neuropathologica
|
December 14, 1999
Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE)
O Schaller, R Fatzer, M Stack, et al.
Diabetes, Nutrition & Metabolism
|
April 27, 2000
Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year study
H Hasche, G Mertes, C Bruns, et al.
Bone Marrow Transplantation
|
June 30, 2009
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies
G Stussi, J Halter, A Tichelli, et al.
Swiss Medical Weekly
|
May 12, 2010
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations
C Taverna, M Bargetzi, D Betticher, et al.
Page
of 13